Name
pdei1
Label
Phosphodiesterase Inhibitors (SHHS1)
Description

Participant taking PHOSPHODIESTERASE INHIBITORS within two weeks of the SHHS1 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
Phosphodiesterase Inhibitors (SHHS1) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No 5,688 - -
Yes 98 - -
Unknown 18 4,080 5,042
Phosphodiesterase Inhibitors (SHHS1) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No 1,426 1,435 1,417 1,410 5,688
Yes 15 13 34 36 98
Unknown 10 3 - 5 18
Phosphodiesterase Inhibitors (SHHS1) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No 2,984 2,704 5,688
Yes 48 50 98
Unknown 7 11 18
Phosphodiesterase Inhibitors (SHHS1) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No - - -
Yes - - -
Unknown 2,219 1,861 4,080
Phosphodiesterase Inhibitors (SHHS1) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No 4,812 497 11 87 278 3 5,688
Yes 85 13 - - - - 98
Unknown 10 5 - 1 2 - 18
Phosphodiesterase Inhibitors (SHHS1) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No - - - - - - -
Yes - - - - - - -
Unknown 3,587 256 8 48 180 1 4,080